Shattuck Labs, Inc. Depreciation
Shattuck Labs, Inc. (STTK) reported Depreciation of $1.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-11
- Shattuck Labs, Inc. depreciation for the quarter ending 2026-06-30 was $851.00K, a 8.40% decline year-over-year.
- Shattuck Labs, Inc. depreciation for the quarter ending 2026-03-31 was $891.00K, a 4.81% decline year-over-year.
- Shattuck Labs, Inc. depreciation for the quarter ending 2025-12-31 was $906.00K, a 3.62% decline year-over-year.
- Shattuck Labs, Inc. depreciation for the quarter ending 2025-09-30 was $917.00K, a 3.78% decline year-over-year.
- Shattuck Labs, Inc. depreciation for fiscal 2025 was $3.69M, a 3.68% decline from fiscal 2024.
- Shattuck Labs, Inc. depreciation for fiscal 2024 was $3.83M, a 5.27% decline from fiscal 2023.
- Shattuck Labs, Inc. depreciation for fiscal 2023 was $4.04M, a 31.53% increase from fiscal 2022.
- Shattuck Labs, Inc. depreciation for fiscal 2022 was $3.07M, a 122.68% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $851.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.74M 10-Q · filed 2026-08-11 | $2.65M derived: sum of 3 quarters · filed 2026-08-11 | $3.56M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $891.00K 10-Q · filed 2026-05-07 | $1.80M derived: sum of 2 quarters · filed 2026-05-07 | $2.71M derived: sum of 3 quarters · filed 2026-05-07 | $3.64M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $906.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.82M derived: sum of 2 quarters · filed 2026-03-05 | $2.75M derived: sum of 3 quarters · filed 2026-08-11 | $3.69M 10-K · filed 2026-03-05 |
| 2025-09-30 | $917.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.85M derived: sum of 2 quarters · filed 2026-08-11 | $2.78M 10-Q · filed 2025-11-06 | $3.72M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $929.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.86M 10-Q · filed 2026-08-11 | $2.81M derived: sum of 3 quarters · filed 2026-08-11 | $3.76M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $936.00K 10-Q · filed 2026-05-07 | $1.88M derived: sum of 2 quarters · filed 2026-05-07 | $2.83M derived: sum of 3 quarters · filed 2026-05-07 | $3.79M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.89M derived: sum of 2 quarters · filed 2026-03-05 | $2.85M derived: sum of 3 quarters · filed 2026-03-05 | $3.83M 10-K · filed 2026-03-05 |
| 2024-09-30 | $953.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.92M derived: sum of 2 quarters · filed 2025-11-06 | $2.89M 10-Q · filed 2025-11-06 | $3.87M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $962.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.94M 10-Q · filed 2025-08-14 | $2.92M derived: sum of 3 quarters · filed 2025-08-14 | $3.94M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $974.00K 10-Q · filed 2025-05-01 | $1.96M derived: sum of 2 quarters · filed 2025-05-01 | $2.98M derived: sum of 3 quarters · filed 2025-05-01 | $4.00M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $981.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.00M derived: sum of 2 quarters · filed 2025-03-27 | $3.03M derived: sum of 3 quarters · filed 2025-03-27 | $4.04M 10-K · filed 2025-03-27 |
| 2023-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $2.05M derived: sum of 2 quarters · filed 2024-11-14 | $3.06M 10-Q · filed 2024-11-14 | $4.07M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $2.04M 10-Q · filed 2024-08-01 | $3.05M derived: sum of 3 quarters · filed 2024-08-01 | $3.98M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $1.01M 10-Q · filed 2024-05-02 | $2.02M derived: sum of 2 quarters · filed 2024-05-02 | $2.95M derived: sum of 3 quarters · filed 2024-05-02 | $3.62M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.94M derived: sum of 2 quarters · filed 2024-02-29 | $2.60M derived: sum of 3 quarters · filed 2024-02-29 | $3.07M 10-K · filed 2024-02-29 |
| 2022-09-30 | $934.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.60M derived: sum of 2 quarters · filed 2023-11-09 | $2.07M 10-Q · filed 2023-11-09 | $2.51M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $662.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.13M 10-Q · filed 2023-08-10 | $1.58M derived: sum of 3 quarters · filed 2023-08-10 | $1.96M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $472.00K 10-Q · filed 2023-05-09 | $915.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.29M derived: sum of 3 quarters · filed 2023-05-09 | $1.62M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $443.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $823.00K derived: sum of 2 quarters · filed 2023-02-23 | $1.15M derived: sum of 3 quarters · filed 2023-02-23 | $1.38M 10-K · filed 2023-02-23 |
| 2021-09-30 | $380.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $709.00K derived: sum of 2 quarters · filed 2022-11-09 | $937.00K 10-Q · filed 2022-11-09 | $1.11M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $329.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $557.00K 10-Q · filed 2022-08-11 | $727.00K derived: sum of 3 quarters · filed 2022-08-11 | $883.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $228.00K 10-Q · filed 2022-05-12 | $398.00K derived: sum of 2 quarters · filed 2022-05-12 | $554.00K derived: sum of 3 quarters · filed 2022-05-12 | $706.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $326.00K derived: sum of 2 quarters · filed 2022-03-15 | $478.00K derived: sum of 3 quarters · filed 2022-03-15 | $618.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $156.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $308.00K derived: sum of 2 quarters · filed 2021-11-09 | $448.00K 10-Q · filed 2021-11-09 | $582.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $152.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $292.00K 10-Q · filed 2021-08-12 | $426.00K derived: sum of 3 quarters · filed 2021-08-12 | |
| 2020-03-31 | $140.00K 10-Q · filed 2021-05-10 | $274.00K derived: sum of 2 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $537.00K 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $403.00K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |